Memantine is a medicine used to help manage symptoms of dementia, like Alzheimer's disease. It works by affecting chemicals in the brain that help with memory and thinking. It's often sold under the brand name Namenda.
Every report comes from a Lived member, sent anonymously.
Have you tried Memantine for Alzheimer's?
Memantine is a prescription medicine for moderate to severe dementia caused by Alzheimer's disease. It is meant to ease symptoms for a time, helping with thinking, memory and everyday tasks such as dressing or eating. It does not slow or stop the disease itself. It was first sold in the US as Namenda (tablets and liquid) and Namenda XR (extended-release capsules). Those brand versions are no longer marketed in the US, but generic memantine is widely available, and the name Ebixa is used in Europe. Namzaric is a single capsule that combines extended-release memantine with donepezil, another Alzheimer's medicine, for people already taking donepezil at a steady dose. Memantine is often added to a cholinesterase inhibitor such as donepezil (Aricept), which works in a different way. Doctors sometimes prescribe it for mild Alzheimer's disease too, but research has not found that it helps at that stage.
Glutamate is a chemical messenger that nerve cells use to signal one another, and it plays a part in learning and memory. It acts partly through docking sites on brain cells called NMDA (N-methyl-D-aspartate) receptors. In Alzheimer's disease, these receptors may be stimulated too much and too constantly, which is thought to add to the symptoms. Memantine partly blocks NMDA receptors, damping down that excess activity while still letting normal signals pass. This explains why it can help some people think and function a little better. It does not repair or protect damaged brain cells, so the disease keeps progressing underneath.
Memantine is taken by mouth, with or without food. It comes as tablets or a liquid taken twice a day, or as extended-release capsules taken once a day. The dose starts low and goes up step by step, usually once a week, until it reaches the usual daily dose. This gradual start helps the body adjust and limits side effects such as dizziness. Extended-release capsules can be swallowed whole or opened and the contents sprinkled on a spoonful of applesauce, which helps people who have trouble swallowing. The whole capsule's contents should be taken at once, and the capsule or beads should not be divided, chewed or crushed. If a dose is missed, skip it and take the next one at the usual time rather than doubling up. If several days are missed, check with the prescriber before restarting, because the dose may need to be built up again from a lower level. People with severe kidney disease usually take a lower dose, since the kidneys clear most of the drug.
Many people take memantine with few noticeable side effects. The most common are dizziness, headache, confusion and constipation. Sleepiness, tiredness, a rise in blood pressure and hallucinations are less common. Dizziness and confusion are most likely after starting or raising the dose. Because dementia itself can cause confusion and hallucinations, it can be hard to tell whether a change comes from the medicine or the disease. A caregiver who notices new or worsening confusion, hallucinations or unusual sleepiness after a dose change should let the prescriber know, since a lower dose may help. Serious reactions have been reported rarely, including severe skin reactions; a blistering or peeling rash needs medical attention the same day.
Memantine is mostly cleared by the kidneys, and how fast that happens depends on how acidic the urine is. When urine becomes more alkaline, memantine can build up in the body and cause more side effects. That can happen with sodium bicarbonate (baking soda, sometimes used as an antacid), with acetazolamide and related drugs (carbonic anhydrase inhibitors, used for glaucoma or altitude sickness), with a severe urinary tract infection or with a major change in diet. Caution is also needed with other drugs that act on the same NMDA receptors: amantadine (used for Parkinson's disease and flu), ketamine (an anesthetic) and dextromethorphan, a cough suppressant found in many over-the-counter cold medicines. Ask a pharmacist before using cough or cold products. Memantine has not been well studied in people with epilepsy, during pregnancy or while breastfeeding, so these situations need a discussion with the prescriber. Anyone who has had an allergic reaction to memantine should not take it.
Benefits, when they appear, are usually modest. In studies of people with moderate to severe Alzheimer's disease, those taking memantine did slightly better than those taking a placebo on tests of thinking, daily activities and overall condition over about six months. For many families the realistic hope is that symptoms hold steady a little longer or decline a little more slowly, rather than that they clearly improve. Some people notice no change at all. Because the benefit is hard to see from day to day, the prescriber usually reviews how things are going with the person and their caregiver every few months, often looking at mood, behavior and daily tasks as well as memory. Memantine does not reliably calm agitation, so that problem usually needs its own plan. Whether benefits continue beyond about six months is not well established, and as dementia advances, families and doctors may decide together whether the medicine is still worth continuing.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Memantine, what you've noticed, or ask the community a question.